Studies in Intravascular Coagulation: IV. The Effect of Heparin and Dicumarol on Serum‐Induced Venous Thrombosis

No abstract is available for this paper.

• Publication year

  1955

• Venue

  Circulation

• Publication date

  1955-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.12.4.553PMID 13261307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factor VII (SPCA): its physiopathologic significance.

  1953cited by this paper
• Analytical Review: Factor VII (SPCA)

  1953cited by this paper
• Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments.

  1953cited by this paper
• Behaviour of factor VII and prothrombin in late pregnancy and in the newborn.

  1952cited by this paper
• Skin tests on serum‐sensitized guinea‐pigs

  1951cited by this paper
• The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.

  1951cited by this paper
• Two-stage procedure for the quantitative determination of prothrombin concentration.

  1949cited by this paper
• A factor in serum which accelerates the conversion of prothrombin to thrombin; its evolution with special reference to the influence of conditions which affect blood coagulation.

  1949cited by this paper
• Estimation of prothrombin level from prothrombin time.

  1947cited by this paper
• Anticoagulant Therapy in Thrombosis

  1946cited by this paper
• Anticoagulant therapy in thrombosis.

  1946cited by this paper
• The adhesiveness of blood platelets in normal subjects with varying concentrations of anti-coagulants

  1941cited by this paper
• THE INHIBITION OF BLOOD CLOTTING: AN UNIDENTIFIED SUBSTANCE WHICH ACTS IN CONJUNCTION WITH HEPARIN TO PREVENT THE CONVERSION OF PROTHROMBIN INTO THROMBIN

  1939cited by this paper
• ON THE ACTION OF HEPARIN AND ITS RELATION TO THROMBOPLASTIN

  1936cited by this paper
• A CLINICAL STUDY OF THE COAGULATION TIME OF BLOOD

  1913cited by this paper

• The History and Historical Treatments of Deep-Vein Thrombosis: Towards the Era of New Anticoagulants.

  2025cites this paper
• ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs

  2019cites this paper
• In Vivo or Ex Vivo Models of Thromobis

  2016cites this paper
• In Vivo or Ex Vivo Models for Testing Thrombosis and Hemostasis

  2015cites this paper
• Blood Constituents and Safety Pharmacology 11

  2013cites this paper
• Time to individualize duration of parenteral anticoagulation in pulmonary thromboembolism?

  2012cites this paper
• Antithrombotic Drugs: Part I

  2012cites this paper
• population-based cohort study recurrence after deep vein thrombosis or pulmonary embolism: a Heparin and warfarin anticoagulation intensity as predictors of

  2011cites this paper
• Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study.

  2011cites this paper
• The Use of Anti-Xa Assay to Monitor Intravenous Unfractionated Heparin Therapy

  2010cites this paper
• Acute pulmonary embolism.

  2010cites this paper
• In vivo models for the evaluation of antithrombotics and thrombolytics.

  2010cites this paper
• Early Discharge of Patients With Venous Thromboembolism: Implications Regarding Therapy

  2010cites this paper
• Anticoagulant Therapy for Acute Venous Thromboembolism: What We Think We Know and What the Data Show for the Timing of Recurrent Events

  2009cites this paper
• Anticoagulant Therapy

  2007cites this paper
• Laboratory Monitoring of Heparin: Challenges and Opportunities

  2007cites this paper
• Pharmacological Assays in Thrombosis and Haemostasis

  2007cites this paper
• Safety Pharmacology of Blood Constituents

  2006cites this paper
• Antithrombotic and Anticoagulant Activities of a Low Molecular Weight Fucoidan by the Subcutaneous Route

  1999cites this paper
• Monitoring Heparin Therapy Using Activated Partial Thromboplastin Time – Results of a Multicenter Trial Establishing the Therapeutic Range for SILIMAT, a Reagent with High Sensitivity to Heparin

  1998cites this paper
• Activity on blood constituents

  1997cites this paper
• Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients.

  1997cites this paper
• Standardization of APTT reagents for heparin therapy monitoring: urgent or fading priority?

  1997cites this paper
• Venous Thrombosis and the “Wessler Test”

  1996cites this paper
• The Antithrombotic Potential of Dalteparin in Man Assessed Indirectly by Wessler’s Technique

  1996cites this paper
• Experimental venous thrombosis induced by homologous serum in the rat.

  1996cites this paper
• Heparin — Controversies and Misconceptions

  1996cites this paper
• Venous Antithrombotic and Anticoagulant Activities of a Fucoïdan Fraction

  1995cites this paper
• Establishing a Therapeutic Range for Heparin Therapy

  1993cites this paper
• Managing the hemorrhagic complications of heparin therapy.

  1993cites this paper
• Relationship between dose, anticoagulant effect and the clinical efficacy and safety of heparin.

  1992cites this paper
• Natural history of progressive ischemic stroke in a population treated with heparin.

  1990cites this paper
• Overview of the Management of Thrombotic Disorders

  1989cites this paper
• [Heparin in deep venous thrombosis of the leg--effectiveness and safety].

  1988cites this paper
• Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial.

  1988cites this paper
• Anticoagulants in venous thromboembolism.

  1988cites this paper
• Recent advances in the management of venous thromboembolism.

  1988cites this paper
• A new experimental model of venous thrombosis in rats involving partial stasis and slight endothelium alterations.

  1987cites this paper
• Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator.

  1987cites this paper
• Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

  1986cites this paper
• Heparin‐induced thrombocytopenia

  1986cites this paper
• Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.

  1985cites this paper
• Anticoagulant therapy.

  1984cites this paper
• High and Low Affinity Heparin Compared with Unfractionated Heparin as Antithrombotic Drugs

  1984cites this paper
• Treatment of thromboembolic disease.

  1982cites this paper
• A comparison of high-dose versus conventional-dose heparin therapy for deep vein thrombosis.

  1982cites this paper
• Indium‐111‐labeled Platelets: Effect of Heparin on Uptake by Venous Thrombi and Relationship to the Activated Partial Thromboplastin Time

  1982cites this paper
• Pulmonary embolism - therapeutic dilemma.

  1981cites this paper
• The effects of heparin treatment on hypertension and vascular lesions in stroke-prone spontaneously hypertensive rats.

  1981cites this paper
• Established venous thrombosis and pulmonary embolism.

  1981cites this paper
• Value of Anticoagulants in the Treatment of Pulmonary Embolism: A Discussion Paper1

  1981cites this paper
• Warfarin anticoagulation in the horse.

  1980cites this paper
• Heparin monitoring and thrombosis.

  1979cites this paper
• Estimation of thrombus formation by labeling of platelets, red cells and fibrinogen in experimental thrombosis.

  1979cites this paper
• Warfarin: effects on anticoagulant, hematologic, and blood enzyme values in normal ponies.

  1979cites this paper
• Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.

  1979cites this paper
• Plasma fibrinopeptide A levels in symptomatic venous thromboembolism.

  1978cites this paper
• Peritoneal dialysis and heparin.

  1978cites this paper
• Pharmacokinetics of heparin after a single intravenous or subcutaneous injection.

  1977cites this paper
• One year of heparin anticoagulation. An ambulatory subject using a totally implantable infusion pump.

  1977cites this paper
• In vivo assessment of anticoagulation.

  1977cites this paper
• Guidelines for the Management of Anticoagulant Therapy

  1976cites this paper
• Anticoagulants and Anticoagulation.

  1976cites this paper
• Laboratory observations and clinical implications of monitoring the effect of heparin by bioassay.

  1976cites this paper
• Therapeutic role of heparin in acute pulmonary embolism.

  1975cites this paper
• Observations in anticoagulant and thrombolytic therapy in pulmonary embolism.

  1975cites this paper
• Conventional Uses of Heparin

  1975cites this paper
• Management of heparin therapy: Controlled prospective trial.

  1975cites this paper
• On the Antithrombotic Action of Heparin

  1974cites this paper
• Variations of heparin therapy for thromboembolic disease.

  1974cites this paper
• HEPRIN TREATMENT IN CHILDHOOD AND ITS EFFECT ON MONITORING TESTS

  1973cites this paper
• Relation between the haemorrhagic and anti-thrombotic action of heparin and warfarin in arterial thrombosis.

  1972cites this paper
• A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

  1972cites this paper
• Monitoring heparin therapy with the activated partial thromboplastin time.

  1971cites this paper
• Peripheral venous thrombophlebitis during pregnancy.

  1971cites this paper
• Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism.

  1971cites this paper
• Heparin therapy by continuous intravenous infusion.

  1971cites this paper
• Effect of Anticoagulating and Non-Anticoagulating Concentrations of Heparin on the Generalized Shwartzman Reaction

  1970cites this paper
• EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE

  1970cites this paper
• The activated partial thromboplastin time in the control of heparin treatment.

  1970cites this paper
• Prophylaxis of pulmonary embolism.

  1970cites this paper
• Changes in adhesiveness and aggegation of platelets after passage of blood through the lungs

  1969cites this paper
• Serum transfusion as a hemostatic procedure.

  1969cites this paper
• The Management of Pulmonary Embolism

  1969cites this paper
• An experimental model for the study of thrombosis

  1968cites this paper
• HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS

  1968cites this paper
• Effect of large doses of warfarin sodium on haemostasis and on ADP-induced platelet aggregation in vivo in the rat. A survey of experimental thrombosis and coumarin anticoagulant therapy.

  1967cites this paper
• The pathogenesis of varicose veins.

  1967cites this paper
• Pulmonary embolism: the value of bedside scanning, angiography and pulmonary embolectomy.

  1967cites this paper
• The pathogenesis of varicose veins.

  1967cites this paper
• Restoration and maintenance of venous patency in venous thrombosis: anticoagulation, thrombectomy and partial venous interruption.

  1967cites this paper
• Some guidelines for heparin therapy of venous thromboembolic disease.

  1967cites this paper
• The dangers of intermitten intravenous heparin therapy.

  1966cites this paper
• Experimental retinal thrombosis.

  1966cites this paper
• THROMBOEMBOLIC DISEASE IN PREGNANCY.

  1965cites this paper
• Treatment of pulmonary embolic disease. A critical review of some aspects of current therapy.

  1965cites this paper
• Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin.

  1965cites this paper
• Lethality of Intravascular Injections of Spleen and Liver Cells

  1964cites this paper
• Anticoagulant Therapy Today

  1964cites this paper
• Die Antikoagulantien in der Therapie der peripheren arteriellen Durchblutungsstörungen

  1964cites this paper